Recent studies indicate that application of anti-PD-1 mAb in HNSCC significantly inhibits proliferation and decreases levels of myeloid-derived suppressor cells (MDSCs) and tumour-associated macrophages (TAMs), while elevating CD8+ cell population levels [49]. Here, CD8A is linked to head and neck squamous cell carcinoma.